These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10182189)

  • 1. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?
    Drummond MF
    Pharmacoeconomics; 1998 Jul; 14(1):1-9. PubMed ID: 10182189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflict of interest in industry-sponsored economic evaluations: real or imagined?
    Barbieri M; Drummond MF
    Curr Oncol Rep; 2001 Sep; 3(5):410-3. PubMed ID: 11489241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethics.
    Matheson A
    BMC Med Ethics; 2016 Apr; 17():20. PubMed ID: 27044283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applied pharmacoeconomics. When can publication be legitimately withheld?
    Yee GC; Hillman AL
    Pharmacoeconomics; 1997 Nov; 12(5):511-6. PubMed ID: 10174317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current state and challenges of pharmacoeconomic evaluation in Korea].
    Choi SE
    J Prev Med Public Health; 2008 Mar; 41(2):74-9. PubMed ID: 18385546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the role of bias in pharmacoeconomic studies.
    Joish VN
    Manag Care Interface; 2001 Aug; 14(8):57-60. PubMed ID: 11517839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America.
    Clemens K; Townsend R; Luscombe F; Mauskopf J; Osterhaus J; Bobula J
    Pharmacoeconomics; 1995 Aug; 8(2):169-74. PubMed ID: 10155611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
    Thwaites R; Townsend RJ
    Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluation of pharmaceuticals: a European perspective.
    Drummond M; Rutten F; Brenna A; Pinto CG; Horisberger B; Jönsson B; Le Pen C; Rovira J; von der Schulenburg MG; Sintonen H
    Pharmacoeconomics; 1993 Sep; 4(3):173-86. PubMed ID: 10146921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When medicine becomes a disease.
    Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sponsorship bias in clinical research.
    Lexchin J
    Int J Risk Saf Med; 2012; 24(4):233-42. PubMed ID: 23135338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between sponsors and investigators in pharmacoeconomic and clinical research.
    Schulman KA; Rubenstein LE; Glick HA; Eisenberg JM
    Pharmacoeconomics; 1995 Mar; 7(3):206-20. PubMed ID: 10155310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomics: an emerging discipline.
    Letizia C
    Qual Assur; 1995 Mar; 4(1):68-74. PubMed ID: 8520866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.